5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18444414 | Substituted (4-Hydroxyphenyl)Cycloalkane and (4-Hydroxyphenyl)Cycloalkene Compounds and Uses Thereof as Selective Agonists of the Estrogen Receptor Beta Isoform for Enhanced Memory Consolidation | OTTON, ALICIA L | 1699 | Non-Final OA | Feb 16, 2024 |
| 18564894 | BZD-1 AS A CHEMOSENSITIZER OF CANCER | MCKOY, QUINCY ANDRE | 1626 | Non-Final OA | Nov 28, 2023 |
| 18197791 | ANTI-MICROBIAL COMPOSITION | ALAWADI, SARAH | 1619 | Final Rejection | May 16, 2023 |
| 17587166 | PSEUDOMONAS CHLORORAPHIS SPECIES AND ITS USE IN THE CONTROL OF DISEASES CAUSED BY BACTERIA AND FUNGI | CRUM, MARY ABOU NADER | 1657 | Non-Final OA | Jan 28, 2022 |
| 17605133 | CAPACITIVE DEIONIZATION WITH ZERO WASTEWATER | KUMAR, SRILAKSHMI K | 1700 | Non-Final OA | Oct 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial